Breaking News: ALS Awareness Month Has Changed — to ALS Action Month

We are a 100% all-volunteer 501(c)(3) non-profit charity. No one takes a paycheck here and there are no administrative costs. That means 100% of all funds raised by the R.A.S.C.A.L.S. Foundation go directly to fighting ALS.

The money goes to fund promising treatment research and development. It helps with ALS family assistance, such as our annual Higher Education Scholarship program.

Categories: 501(c)(3) Non-Profit, ALS Community News, ALS Families, ALS News, Caretakers  |  Tags: 501(c)(3) ALS charity, ALS, ALS Awareness Month, ALS charity, ALS community, ALS cure, ALS diagnosis, ALS donations, ALS funding, ALS medical care, ALS research, ALS research funding, ALS treatments, amyotrophic lateral sclerosis, Bob Stehlin, Lou Gehrig's disease, PALS, RASCALS Foundation, Robert A. Stehlin Campaign for ALS, St.Louis RASCALS ALS Lou Gehrig's Disease amotrophic lateral sclerosis  |  No comments

110% Gratitude to All Our Volunteers

April marks National Volunteer Month. This observance holds very special meaning for all of us here at the Robert A. Stehlin Campaign for ALS (R.A.S.C.A.L.S.). That’s because we are a 100% all-volunteer 501(c)(3) non-profit charity. There are no administrative costs.
That means no salaries, payments, or perks for anyone. Out-of-pocket expenses truly means out of our [...]

Categories: 501(c)(3) Non-Profit, ALS Community News, ALS Families, ALS News, RASCALS Foundation News, Treatments  |  Tags: 501(c)(3) ALS charity, ALS, ALS Awareness Month, ALS community, ALS cure, ALS diagnosis, ALS diagnostics, ALS donations, ALS funding, ALS medical care, ALS research, ALS research funding, ALS treatments, ALS volunteers, amyotrophic lateral sclerosis, Bob Stehlin, Lou Gehrig's disease, PALS, RASCALS Foundation, Robert A. Stehlin Campaign for ALS, St.Louis RASCALS ALS Lou Gehrig's Disease amotrophic lateral sclerosis  |  No comments

Cytokinetics Inc. Announces Initiation of First-Time-in-Humans, Phase I Clinical Trial of CK-2127107

Cytokinetics, Incorporated announced today the initiation of a first-time-in-humans, Phase I clinical trial of CK-2127107 in healthy male volunteers. Cytokinetics is developing CK-2127107, a novel small molecule activator of the fast skeletal muscle troponin complex, for the potential improvement of skeletal muscle function in diseases and medical conditions associated with neuromuscular dysfunction, muscular weakness, and/or muscle fatigue. Like tirasemtiv, the lead drug candidate from the company’s skeletal muscle activator program, CK-2127107 slows the rate of calcium release from the regulatory troponin complex of fast skeletal muscle fibers, which sensitizes the sarcomere to calcium.

Categories: ALS News, Clinical Trials, Research News, Treatments, Uncategorized  |  Tags: ALS, ALS community, ALS funding, ALS medical care, ALS research, ALS research funding, ALS treatments, amyotrophic lateral sclerosis, Background on Fast Skeletal Muscle Activators ALS, BENEFIT-ALS (Blinded Evaluation of Neuromusclar Effects and Functional Improvement with Tirasemtiv in ALS), Bob Stehlin, CK-2127107, Cytokinetics Incorporated, Fady Malik, Lou Gehrig's disease, novel mechanism ALS, PALS, Phase I clinical trial, Phase I clinical trial CK-2127107, RASCALS Foundation, Robert A. Stehlin Campaign for ALS, Robert I. Blum, St.Louis RASCALS ALS Lou Gehrig's Disease amotrophic lateral sclerosis, tirasemtiv ALS  |  No comments

‘No White Flags’: Steve Gleason Builds Movement Against ALS

“I believe happiness is a choice. Some days it is a very difficult choice,” he says. “This is true for everyone. I look at the human life like an experiment. Every new moment, every new experience, tragic or otherwise, is an opportunity to gain a more accurate perspective and helps lead me to clarity.”

Categories: 501(c)(3) Non-Profit, Caretakers, Clinical Trials, Research News, Technology, Treatments  |  Tags: 501(c)(3) ALS charity, Aaron Rodgers, ALS Awareness Month, ALS charity, ALS community, ALS cure, ALS funding, ALS medical care, ALS research, ALS research funding, ALS treatments, amyotrophic lateral sclerosis, Bob Stehlin, chronic traumatic encephalopathy, chronic traumatic encephalopathy (CTE), Drew Brees, eye-tracking software ALS, global philanthropy JPMorgan Chase, Jay Rink, Jeff Duncan, Lake Pontchartrain, Lois Backon, Lou Gehrig's disease, Michel Gleason, Mike McCarthy, New Orleans Saints, O.J. Brigance, PALS, Paul Varisco and the Milestones, RASCALS Foundation, Ray Lewis, Rick Crozier, Rivers Gleason, Robert A. Stehlin Campaign for ALS, Scott Fujita, St.Louis RASCALS ALS Lou Gehrig's Disease amotrophic lateral sclerosis, Stephen Jackson, Steve Gleason, Steve Gleason No White Flags, Super Bowl, Super Bowl Host Committee legacy project, Team Gleason, Team Gleason Experiment, Team Gleason House, UN Social Innovation Summit, USA Today Sports, Vinnie Varisco  |  No comments

NFL Players and Coaches Come Together for New Team Gleason ALS Message

# # #
The Robert A. Stehlin Campaign for ALS (R.A.S.C.A.L.S.) is an all-volunteer 501(c)(3) charity. 100% of all funds raised go to building awareness, treatment research and development, plus ALS family assistance. There are no administrative costs.
Contributions are tax-deductible.
You may also be interested in visiting the RASCALS Store.
The material presented here is for informational purposes [...]

Categories: 501(c)(3) Non-Profit, Caretakers, Research News, Technology, Treatments  |  Tags: 501(c)(3) ALS charity, ALS, ALS Awareness Month, ALS charity, ALS community, ALS cure, ALS donations, ALS funding, ALS medical care, ALS research, ALS research funding, ALS treatments, amyotrophic lateral sclerosis, Bob Stehlin, breakthrough, Lou Gehrig's disease, PALS, RASCALS Foundation, Robert A. Stehlin Campaign for ALS, St.Louis RASCALS ALS Lou Gehrig's Disease amotrophic lateral sclerosis, Steve Gleason, Team Gleason  |  No comments

Stem Cells May Hold Promise for Lou Gehrig’s Disease (ALS)

The study found that stem cell transplantation significantly extended the lifespan of the mice by 20 days and improved their neuromuscular function by 15 percent. “Our study shows promise for testing stem cell transplantation in human clinical trials,” said Corti.

Categories: Research News, Treatments  |  Tags: ALS, ALS community, ALS cure, ALS funding, ALS mice, ALS research, ALS research funding, ALS treatments, American Academy of Neurology, amyotrophic lateral sclerosis, AriSLA, Bob Stehlin, effective cell-based treatment for ALS, induced pluripotent stem cells (iPSCs) ALS, iPSC, Italian Foundation for Research on Amyotrophic Lateral Sclerosis, Lou Gehrig's disease, RASCALS Foundation, Robert A. Stehlin Campaign for ALS, SOD1, St.Louis RASCALS ALS Lou Gehrig's Disease amotrophic lateral sclerosis, Stefania Corti, Stem cell transplants, Stem cell transplants ALS, University of Milan  |  No comments

Winged Warrior Award 2012: Julie Tristan

ST. LOUIS, Missouri, January 12, 2013 — The Robert A. Stehlin Campaign for ALS (R.A.S.C.A.L.S.) presented their annual Winged Warrior award to Julie Tristan, anchor-reporter for KSDK’s Show Me St. Louis.
The presentation was made at the RASCALS’ recent Trivia Night, for which Julie has been the Master of Ceremonies since the inaugural event in [...]

Categories: 501(c)(3) Non-Profit, Caretakers, RASCALS Foundation News, Technology, Treatments  |  Tags: 501(c)(3) ALS charity, ALS, ALS Awareness Month, ALS charity, ALS community, ALS cure, ALS diagnosis, ALS diagnostics, ALS donations, ALS funding, ALS medical care, ALS research, ALS research funding, ALS treatments, amyotrophic lateral sclerosis, Bob Stehlin, breakthrough, FDA, Lou Gehrig's disease, PALS, RASCALS Foundation, Robert A. Stehlin Campaign for ALS, St.Louis RASCALS ALS Lou Gehrig's Disease amotrophic lateral sclerosis, stem cells  |  No comments

2013: Let’s Make History

THIS IS OUR YEAR.
THIS IS OUR MOMENT.
THIS IS THE TIME TO STEP UP AGAINST ALS.
Researchers continue to make breakthroughs in understanding how ALS functions.
There’s also been some promising news about potential treatments.
That’s why now is the time to swing for the fences.
So please dig in, dig deep, and make a donation to the RASCALS Foundation.
Step [...]

Categories: 501(c)(3) Non-Profit, Caretakers, Clinical Trials, RASCALS Foundation News, Research News, Treatments  |  Tags: 501(c)(3) ALS charity, ALS, ALS community, ALS cure, ALS diagnosis, ALS diagnostics, ALS donations, ALS funding, ALS medical care, ALS research, ALS research funding, ALS treatments, amyotrophic lateral sclerosis, Bob Stehlin, breakthrough, Lou Gehrig's disease, PALS, RASCALS Foundation, Robert A. Stehlin Campaign for ALS, St.Louis RASCALS ALS Lou Gehrig's Disease amotrophic lateral sclerosis  |  No comments

Christmas Wish

The RASCALS Foundation
Would Like To Wish Everyone Around the World
A Happy Holiday Season and A Healthy Happy New Year!
The Foundation`s Christmas Wish is  Through
The Efforts of Research Leading to Effective Treatments and One Day,
A Cure for ALS!
The Robert A. Stehlin Campaign for ALS (R.A.S.C.A.L.S.) is an all-volunteer 501(c)(3) charity. 100% of all [...]

Categories: RASCALS Foundation News  |  Tags: 501(c)(3) ALS charity, ALS community, ALS donations, ALS funding, amyotrophic lateral sclerosis, Bob Stehlin, Christmas Wishes, Lou Gehrig's disease, RASCALS Foundation, Robert A. Stehlin Campaign for ALS, St.Louis RASCALS ALS Lou Gehrig's Disease amotrophic lateral sclerosis  |  No comments

$2.1M Awarded to Scripps Scientists to Study Several Compounds with Potential to Improve QOL for ALS Patients

A team led by scientists at The Scripps Research Institute has been awarded $2.1 million by the Department of Defense Congressionally Directed Medical Research Programs to study several compounds with the potential to greatly improve the quality of life for those with amyotrophic lateral sclerosis (ALS) or Lou Gehrig’s disease.

Categories: Research News, Technology, Treatments  |  Tags: ALS, ALS community, ALS funding, ALS medical care, ALS research, amyotrophic lateral sclerosis, Bob Stehlin, c-Jun N-terminal kinase, Columbia University, Department of Defense, Lou Gehrig's disease, Motor Neuron Disease, motor neurone disease, PALS, Philip LoGrasso, RASCALS Foundation, Robert A. Stehlin Campaign for ALS, Scripps, St.Louis RASCALS ALS Lou Gehrig’s Disease amotrophic lateral sclerosis, The Scripps Research Institute  |  No comments